化合物 Ritlecitinib tosylate T69822
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
50 mg | 2192215-81-7 | ¥13,800.00 | 询底价 |
25 mg | 2192215-81-7 | ¥10,600.00 | 询底价 |
100 mg | 2192215-81-7 | ¥17,500.00 | 询底价 |
Product Introduction
Bioactivity
英文名: Ritlecitinib tosylate
描述: Ritlecitinib, also known as PF-06651600, is a potent and selective JAK3 inhibitor. PF-06651600 is a potent and low clearance compound with demonstrated in vivo efficacy. The favorable efficacy and safety profile of this JAK3-specific inhibitor PF-06651600 led to its evaluation in several human clinical studies. JAK3 was among the first of the JAKs targeted for therapeutic intervention due to the strong validation provided by human SCID patients displaying JAK3 deficiencies.
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
关键字: MC-4 | Ritlecitinib Tosylate | MC 4
化合物 Ritlecitinib tosylate T69822信息由TargetMol中国为您提供,如您想了解更多关于化合物 Ritlecitinib tosylate T69822报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途